nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass
|
Steenackers, Nele |
|
|
6 |
3 |
p. 225-237 |
artikel |
2 |
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
|
Petroff, David |
|
|
6 |
3 |
p. 185-198 |
artikel |
3 |
CAP for the detection of hepatic steatosis in clinical practice
|
Ferraioli, Giovanna |
|
|
6 |
3 |
p. 151-152 |
artikel |
4 |
Correction to Lancet Gastroenterol Hepatol 2020; 5: 598–606
|
|
|
|
6 |
3 |
p. e2 |
artikel |
5 |
COVID-19 hits viral hepatitis care for vulnerable populations
|
Samarasekera, Udani |
|
|
6 |
3 |
p. 166 |
artikel |
6 |
Crohn's warrior
|
Wortley, Chris |
|
|
6 |
3 |
p. 168 |
artikel |
7 |
Distinguishing intestinal tuberculosis from Crohn's disease
|
Jena, Anuraag |
|
|
6 |
3 |
p. 159 |
artikel |
8 |
Distinguishing intestinal tuberculosis from Crohn's disease – Authors' reply
|
Banerjee, Rupa |
|
|
6 |
3 |
p. 159-160 |
artikel |
9 |
Effect of COVID-19 on colorectal cancer care in England
|
Turnbull, Clare |
|
|
6 |
3 |
p. 152-154 |
artikel |
10 |
Effect of COVID-19 on viral hepatitis services in Pakistan
|
Mustafa, Zia Ul |
|
|
6 |
3 |
p. 163-164 |
artikel |
11 |
Endorsing the redefinition of fatty liver disease
|
Tan, Soek Siam |
|
|
6 |
3 |
p. 163 |
artikel |
12 |
Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study
|
Dugan, Ellen |
|
|
6 |
3 |
p. 169-184 |
artikel |
13 |
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study
|
Morris, Eva J A |
|
|
6 |
3 |
p. 199-208 |
artikel |
14 |
Labour pains: eliminating HCV in women and children
|
Judd, Ali |
|
|
6 |
3 |
p. 150-151 |
artikel |
15 |
Personalised dosimetry for SIRT: new standard or bridge to surgical resection?
|
Ronot, Maxime |
|
|
6 |
3 |
p. 161 |
artikel |
16 |
Personalised dosimetry for SIRT: new standard or bridge to surgical resection? – Authors' reply
|
Garin, Etienne |
|
|
6 |
3 |
p. 162 |
artikel |
17 |
Prevention and treatment of nutritional complications after bariatric surgery
|
Nuzzo, Alexandre |
|
|
6 |
3 |
p. 238-251 |
artikel |
18 |
Provision of healthy public food: leading by example
|
The Lancet Gastroenterology & Hepatology, |
|
|
6 |
3 |
p. 149 |
artikel |
19 |
Research in brief
|
Baker, Holly |
|
|
6 |
3 |
p. 167 |
artikel |
20 |
Safety and activity of trifluridine/tipiracil and ramucirumab in previously treated advanced gastric cancer: an open-label, single-arm, phase 2 trial
|
Kawazoe, Akihito |
|
|
6 |
3 |
p. 209-217 |
artikel |
21 |
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement
|
Alexander, James L |
|
|
6 |
3 |
p. 218-224 |
artikel |
22 |
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question
|
Marjot, Thomas |
|
|
6 |
3 |
p. 156-158 |
artikel |
23 |
Stercoral perforation due to chronic constipation
|
Chen, Andy Ze Lin |
|
|
6 |
3 |
p. 252 |
artikel |
24 |
The ileoanal pouch: the next frontier in inflammatory bowel disease
|
Segal, Jonathan P |
|
|
6 |
3 |
p. 164-165 |
artikel |
25 |
Treatment eligibility in hepatitis B: a call for better linkage to optimal care
|
Huang, Daniel Q |
|
|
6 |
3 |
p. 160 |
artikel |
26 |
Trifluridine/tipiracil plus ramucirumab in gastric cancer
|
Zhu, Mojun |
|
|
6 |
3 |
p. 154-155 |
artikel |